Cargando…
Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
Crohn’s Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the pr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100971/ https://www.ncbi.nlm.nih.gov/pubmed/27824890 http://dx.doi.org/10.1371/journal.pone.0165782 |
_version_ | 1782466226517180416 |
---|---|
author | Lo, Wing-Cheong Arsenescu, Violeta Arsenescu, Razvan I. Friedman, Avner |
author_facet | Lo, Wing-Cheong Arsenescu, Violeta Arsenescu, Razvan I. Friedman, Avner |
author_sort | Lo, Wing-Cheong |
collection | PubMed |
description | Crohn’s Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the present paper, we develop a mathematical model, by a system of differential equations, which describe the dynamic relations among these T cells and their cytokines. The model identities four groups of CD patients according to up/down regulation of Th1 and Th2. The model simulations show that immunosuppression by TNF-α blockage benefits the group with Th1(High)/Th2(Low) while, by contrast, the group with Th1(Low)/Th2(High) will benefit from immune activation. |
format | Online Article Text |
id | pubmed-5100971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51009712016-11-18 Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? Lo, Wing-Cheong Arsenescu, Violeta Arsenescu, Razvan I. Friedman, Avner PLoS One Research Article Crohn’s Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the present paper, we develop a mathematical model, by a system of differential equations, which describe the dynamic relations among these T cells and their cytokines. The model identities four groups of CD patients according to up/down regulation of Th1 and Th2. The model simulations show that immunosuppression by TNF-α blockage benefits the group with Th1(High)/Th2(Low) while, by contrast, the group with Th1(Low)/Th2(High) will benefit from immune activation. Public Library of Science 2016-11-08 /pmc/articles/PMC5100971/ /pubmed/27824890 http://dx.doi.org/10.1371/journal.pone.0165782 Text en © 2016 Lo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lo, Wing-Cheong Arsenescu, Violeta Arsenescu, Razvan I. Friedman, Avner Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? |
title | Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? |
title_full | Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? |
title_fullStr | Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? |
title_full_unstemmed | Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? |
title_short | Inflammatory Bowel Disease: How Effective Is TNF-α Suppression? |
title_sort | inflammatory bowel disease: how effective is tnf-α suppression? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100971/ https://www.ncbi.nlm.nih.gov/pubmed/27824890 http://dx.doi.org/10.1371/journal.pone.0165782 |
work_keys_str_mv | AT lowingcheong inflammatoryboweldiseasehoweffectiveistnfasuppression AT arsenescuvioleta inflammatoryboweldiseasehoweffectiveistnfasuppression AT arsenescurazvani inflammatoryboweldiseasehoweffectiveistnfasuppression AT friedmanavner inflammatoryboweldiseasehoweffectiveistnfasuppression |